GlassScriptPhysician profile
Meredith Mcamis
NPI 1003094251
$5,568.56
in general payments reported to CMS, 2019-2025
19 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $481 · 2022: $829 · 2023: $2,013 · 2024: $1,106 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,313 · Travel and Lodging: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,313.34 |
| Travel and Lodging | $944.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,610.03 | 2021-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,095.28 | 2023 | |
| Novo Nordisk INC | $524.19 | 2022-2025 | Wegovy |
| Depuy Synthes Sales INC. | $522.51 | 2022-2024 | Matrixrib |
| Ethicon US, LLC | $297.27 | 2021-2023 | Linx Reflux Management System |
| Vertex Pharmaceuticals Incorporated | $250.10 | 2025 | |
| Acera Surgical, INC. | $239.92 | 2021-2025 | Restrata Wound Matrix |
| Davol INC. | $239.35 | 2022-2024 | |
| Inspire Medical Systems, INC. | $187.79 | 2023-2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $123.80 | 2024 | Voquezna |
| Lilly USA, LLC | $117.79 | 2022-2024 | Zepbound |
| Alexion Pharmaceuticals, INC. | $90.80 | 2025 | |
| Medtronic, INC. | $81.76 | 2023-2025 | Signia, Corevalve Evolut R, Maxtack |
| Kci USA, INC. | $72.73 | 2023 | Abthera Advance |
| Tela Bio, INC. | $50.00 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $23.23 | 2023 | Exparel |
| Kerecis Limited | $18.29 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $15.96 | 2024 | Bridion |
| Endogastric Solutions, INC | $7.76 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Mcamis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.